As a leading provider of outsourced early drug development services, WCCT Global partners with pharmaceutical, biotechnology, and medical device industries to offer regulatory guidance, program management, patient recruitment, data management, and strategic consulting. Their focus lies in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. On February 19, 2020, WCCT Global joined Altasciences to further their mission of advancing global health through early phase drug development.